Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen (Page 5 of 5)

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Never Share an Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen Between Patients

Advise patients using Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPens not to share needles or KwikPens with another person. Sharing poses a risk for transmission of blood-borne pathogens [see Warnings and Precautions (5.1)].

Hyperglycemia or Hypoglycemia

Inform patients that hypoglycemia is the most common adverse reaction with insulin. Instruct patients on self-management procedures including glucose monitoring, proper injection technique, and management of hypoglycemia and hyperglycemia, especially at initiation of Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 therapy. Instruct patients on handling of special situations such as intercurrent conditions (illness, stress, or emotional disturbances), an inadequate or skipped insulin dose, inadvertent administration of an increased insulin dose, inadequate food intake, and skipped meals. Instruct patients on the management of hypoglycemia [see Warnings and Precautions (5.3)].

Inform patients that their ability to concentrate and react may be impaired as a result of hypoglycemia. Advise patients who have frequent hypoglycemia or reduced or absent warning signs of hypoglycemia to use caution when driving or operating machinery.

Advise patients that changes in insulin regimen can predispose to hyperglycemia or hypoglycemia and that changes in insulin regimen should be made under close medical supervision [see Warnings and Precautions (5.2)].

Hypoglycemia due to Medication Errors

Instruct patients to always check the insulin label before each injection to avoid mix-ups between insulin products [see Warnings and Precautions (5.4)].

Hypersensitivity Reactions

Advise patients that hypersensitivity reactions have occurred with Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25. Inform patients on the symptoms of hypersensitivity reactions and to seek medical attention if they occur [see Warnings and Precautions (5.5)].

Manufactured by Eli Lilly and Company

Indianapolis, IN 46285, USA

Copyright © 1999, 2020, Eli Lilly and Company. All rights reserved.

ILPILIS7525-0001-USPI-20200110

This Patient Information has been approved by the U.S. Food and Drug Administration.

Issued: February 2020

Patient Information Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25™ for subcutaneous use
Do not share your Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
What is Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25?
  • Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 is a man-made insulin that is used to control high blood sugar in people with diabetes mellitus.
  • It is not known if Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 is safe and effective in children under 18 years of age.
Who should not take Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25? Do not take Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 if you:
  • are having an episode of low blood sugar (hypoglycemia).
  • have an allergy to Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 or any of the ingredients in Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25. See the end of this Patient Information leaflet for a complete list of ingredients in Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25.
What should I tell my healthcare provider before taking Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25? Before taking Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25, tell your healthcare provider about all of your medical conditions, including if you:
  • have liver or kidney problems.
  • take any other medicines, especially ones called TZDs (thiazolidinediones).
  • have heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25.
  • are pregnant or plan to become pregnant. Talk with your healthcare provider about the best way to control your blood sugar if you plan to become pregnant or while you are pregnant.
  • are breastfeeding or plan to breastfeed. Talk with your healthcare provider about the best way to feed your baby while taking Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.Before you start taking Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25, talk to your healthcare provider about low blood sugar and how to manage it.
How should I take Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25?
  • Read the Instructions for Use that comes with your Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25.
  • Take Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 exactly as your healthcare provider tells you to. Your healthcare provider should tell you how much Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 to take and when to take it.
  • Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 starts acting fast. Inject Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 within 15 minutes before you eat a meal.
  • Know the type, strength, and amount of insulin you take. Do not change the type or amount of insulin you take unless your healthcare provider tells you to. The amount of insulin and the best time for you to take your insulin may need to change if you take different types of insulin.
  • Check your insulin label each time you give your injection to make sure you are taking the correct insulin.
  • Inject Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 under the skin (subcutaneously) of your stomach area (abdomen), buttocks, upper legs or upper arms. Do not inject Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 into your vein (intravenously) or muscle (intramuscularly) or use in an insulin infusion pump.
  • Change (rotate) your injection sites within the area you choose with each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.
    • Do not use the exact same spot for each injection.
    • Do not inject where the skin has pits, is thickened, or has lumps.
    • Do not inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
  • Do not mix Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 with other insulins or liquids.
  • Check your blood sugar levels. Ask your healthcare provider what your blood sugars should be and when you should check your blood sugar levels.
Keep Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 and all medicines out of the reach of children.
Your dose of Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 may need to change because of a:
  • change in physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or because of other medicines you take.
What should I avoid while taking Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25? While taking Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 do not:
  • drive or operate heavy machinery until you know how Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 affects you.
  • drink alcohol or take prescription or over-the-counter medicines that contain alcohol.
What are the possible side effects of Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25? Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 may cause serious side effects that can lead to death, including:
  • low blood sugar (hypoglycemia). Signs and symptoms of low blood sugar may include:
  • dizziness or light-headedness
  • sweating
  • confusion
  • headache
  • blurred vision
  • slurred speech
  • shakiness
  • fast heartbeat
  • anxiety, irritability or mood changes
  • hunger
Your healthcare provider may prescribe a glucagon emergency kit so that someone else can give you glucagon if your blood sugar becomes too low (severe hypoglycemia) and you are unable to take sugar by mouth.
  • severe allergic reaction (whole body reaction). Get medical help right away, if you have any of these signs or symptoms of a severe allergic reaction:
  • a rash over your whole body
  • trouble breathing
  • a fast heartbeat
  • sweating
  • low potassium in your blood (hypokalemia).
  • heart failure. Taking certain diabetes pills called thiazolidinediones or “TZDs” with Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 may cause heart failure in some people. This can happen even if you have never had heart failure or heart problems before. If you already have heart failure it may get worse while you take TZDs with Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25. Your healthcare provider should monitor you closely while you are taking TZDs with Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25. Tell your healthcare provider if you have any new or worse symptoms of heart failure including:
  • shortness of breath
  • swelling of your ankles or feet
  • sudden weight gain
Treatment with TZDs and Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 may need to be adjusted or stopped by your healthcare provider if you have new or worse heart failure.Get emergency medical help if you have:
  • trouble breathing
  • shortness of breath
  • fast heartbeat
  • swelling of your face, tongue, or throat
  • sweating
  • extreme drowsiness
  • dizziness
  • confusion
The most common side effects of Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 include:
  • low blood sugar (hypoglycemia)
  • reactions at your injection site
  • skin thickening or pits at the injection site (lipodystrophy)
  • weight gain
  • swelling in your hands or feet
  • itching
  • rash
These are not all the possible side effects of Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General information about the safe and effective use of Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not take Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 for a condition for which it was not prescribed. Do not give Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 to other people, even if they have the same symptoms that you have. It may harm them.This Patient Information leaflet summarizes the most important information about Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 that is written for health professionals.
What are the ingredients in Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25? Active ingredients: insulin lisproInactive ingredients: protamine sulfate, glycerin, dibasic sodium phosphate, metacresol, zinc oxide (zinc ion), phenol and water for injection.Mix75/25™ and KwikPen® are trademarks of Eli Lilly and Company.Manufactured by Eli Lilly and Company, Indianapolis, IN 46285, USA Copyright © 1999, 2020, Eli Lilly and Company. All rights reserved.For more information, call 1-800-545-5979.

ILPILIS7525-0001-PPI-20200207

Instructions for Use

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25™ KwikPen ®

for subcutaneous use

3 mL single-patient-use pen (100 units/mL)

Figure
(click image for full-size original)

Read this Instructions for Use before you start taking Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 and each time you get another KwikPen. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

Do not share your Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen (“Pen”) is a disposable single-patient-use prefilled pen containing 300 units of Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25.

• You can give yourself more than 1 dose from the Pen.

• By turning the Dose Knob, you can dial doses from 1 to 60 units in 1 unit increments.

If your dose is more than 60 units, you will need to give yourself more than 1 injection.

• The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 300 units in the Pen.

People who are blind or have vision problems should not use this Pen without help from a person trained to use the Pen.

Figure
(click image for full-size original)

Figure
(click image for full-size original)

How to recognize your Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen

  • Pen color: Dark blue
  • Dose Knob: Dark blue
  • Labels: White label with yellow stripe

Supplies you will need to give your injection

  • Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen
  • KwikPen compatible Needle (Becton, Dickinson and Company Pen Needles recommended)
  • Alcohol swab
  • Gauze

Preparing your Pen

  • Wash your hands with soap and water.
  • Check your Pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.
  • Always use a new needle for each injection to help prevent infections and blocked needles. Do not reuse or share your needles with other people. You may give other people a serious infection or get a serious infection from them.
Step 1:
  • Pull the Pen Cap straight off.
    Do not remove the Pen Label.
  • Wipe the Rubber Seal with an alcohol swab.
    Do not attach the Needle before mixing.
Figure
Step 2:
  • Gently roll the Pen between your hands at least 10 times.
Figure
Step 3:
  • Move the Pen up and down (invert) at least 10 times.Mixing by rolling and inverting the Pen is important to make sure you get the right dose. After mixing Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25, inject your dose right away. If you wait to inject your dose, the insulin will need to be mixed again.
Figure
Step 4:
  • Check the liquid in the Pen. Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 should look white and cloudy after mixing. Do not use if it looks clear or has any lumps or particles in it.
Step 5:
  • Select a new Needle.
  • Pull off the Paper Tab from the Outer Needle Shield.
Figure
Step 6:
  • Push the capped Needle straight onto the Pen and twist the Needle on until it is tight.
Figure
Step 7:
  • Pull off the Outer Needle Shield. Do not throw it away.
  • Pull off the Inner Needle Shield and throw it away.
Figure

Priming your Pen

Prime your Pen before each injection.

  • Priming your Pen means removing the air from the Needle and Cartridge that may collect during normal use and ensures that the Pen is working correctly.
  • If you do not prime before each injection, you may get too much or too little insulin.
Step 8:
  • To prime your Pen, turn the Dose Knob to select 2 units.
Figure
Step 9:
  • Hold your Pen with the Needle pointing up. Tap the Cartridge Holder gently to collect air bubbles at the top.
Figure
Step 10:
  • Continue holding your Pen with Needle pointing up. Push the Dose Knob in until it stops, and “0” is seen in the Dose Window. Hold the Dose Knob in and count to 5 slowly.
  • You should see insulin at the tip of the Needle.
    If you do not see insulin, repeat priming steps 8 to 10, no more than 4 times.
    If you still do not see insulin, change the Needle and repeat priming steps 8 to 10.
Small air bubbles are normal and will not affect your dose.
Figure
(click image for full-size original)
Figure

Selecting your dose

  • You can give from 1 to 60 units in a single injection.
  • If your dose is more than 60 units, you will need to give more than one injection.
    If you need help with dividing up your dose the right way, ask your healthcare provider.
    Use a new Needle for each injection and repeat the priming steps.
Step 11:
  • Turn the Dose Knob to select the number of units you need to inject. The Dose Indicator should line up with your dose.
    The Pen dials 1 unit at a time.
    The Dose Knob clicks as you turn it.
    Do not dial your dose by counting the clicks. You may dial the wrong dose. This may lead to you getting too much insulin or not enough insulin.
    The dose can be corrected by turning the Dose Knob in either direction until the correct dose lines up with the Dose Indicator.
    The even numbers (for example, 12) are printed on the dial.
    The odd numbers, (for example, 25) after the number 1, are shown as full lines.
  • Always check the number in the Dose Window to make sure you have dialed the correct dose.
Figure
Figure
(Example: 12 units shown in the Dose Window)Figure
(Example: 25 units shown in the Dose Window)
  • The Pen will not let you dial more than the number of units left in the Pen.
  • If you need to inject more than the number of units left in the Pen, you may either:
    inject the amount left in your Pen and then use a new Pen to give the rest of your dose, or
    get a new Pen and inject the full dose.
  • It is normal to see a small amount of insulin left in the Pen that you can not inject.

Giving your injection

  • Inject your insulin as your healthcare provider has shown you.
  • Change (rotate) your injection sites within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.
  • Do not inject where the skin has pits, is thickened, or has lumps.
  • Do not inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.
  • Do not try to change your dose while injecting.
Step 12:
  • Choose your injection site.Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.
  • Wipe your skin with an alcohol swab, and let your skin dry before you inject your dose.
Figure
Step 13:
  • Insert the Needle into your skin.
  • Push the Dose Knob all the way in.
  • Continue to hold the Dose Knob in and slowly count to 5 before removing the Needle.Figure
Do not try to inject your insulin by turning the Dose Knob. You will not receive your insulin by turning the Dose Knob.
Figure
Step 14:
  • Pull the Needle out of your skin.A drop of insulin at the Needle tip is normal. It will not affect your dose.
  • Check the number in the Dose Window.
    If you see “0” in the Dose Window, you have received the full amount you dialed.
    If you do not see “0” in the Dose Window, do not redial. Insert the Needle into your skin and finish your injection.
    If you still do not think you received the full amount you dialed for your injection, do not start over or repeat the injection. Monitor your blood glucose as instructed by your healthcare provider.
    If you normally need to give 2 injections for your full dose, be sure to give your second injection.
The Plunger only moves a little with each injection, and you may not notice that it moves.If you see blood after you take the Needle out of your skin, press the injection site lightly with a piece of gauze or an alcohol swab. Do not rub the area.
Figure

After your injection

Step 15:
  • Carefully replace the Outer Needle Shield.
Figure
Step 16:
  • Unscrew the capped Needle and throw it away (see Disposing of Pens and Needles section).
  • Do not store the Pen with the Needle attached to prevent leaking, blocking the Needle, and air from entering the Pen.
Figure
Step 17:
  • Replace the Pen Cap by lining up the Cap Clip with the Dose Indicator and pushing straight on.
Figure

Disposing of Pens and Needles

  • Put your used needles in a FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) loose needles in your household trash.
  • If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:
    made of a heavy-duty plastic,
    can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
    upright and stable during use,
    leak-resistant, and
    properly labeled to warn of hazardous waste inside the container.
  • When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at: http://www.fda.gov/safesharpsdisposal
  • Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle your used sharps disposal container.
  • The used Pen may be discarded in your household trash after you have removed the needle.

Storing your Pen

Unused Pens

  • Store unused Pens in the refrigerator at 36°F to 46°F (2°C to 8°C).
  • Do not freeze your insulin. Do not use if Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 has been frozen.
  • Unused Pens may be used until the expiration date printed on the Label, if the Pen has been kept in the refrigerator.
  • Unused Pens stored at room temperature, below 86°F (30°C), should be thrown away after 10 days.

In-use Pen

  • Store the Pen you are currently using at room temperature [up to 86°F (30°C)]. Keep away from heat and light.
  • Throw away the Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 Pen you are using after 10 days, even if it still has insulin left in it.

General information about the safe and effective use of your Pen

  • Keep your Pen and needles out of the reach of children.
  • Do not use your Pen if any part looks broken or damaged.
  • Always carry an extra Pen in case yours is lost or damaged.

Troubleshooting

  • If you can not remove the Pen Cap, gently twist the cap back and forth, and then pull the cap straight off.
  • If the Dose Knob is hard to push:
    Pushing the Dose Knob more slowly will make it easier to inject.
    Your Needle may be blocked. Put on a new Needle and prime the Pen.
    You may have dust, food, or liquid inside the Pen. Throw the Pen away and get a new Pen.

If you have any questions or problems with your Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.

Mix75/25™ and KwikPen® are trademarks of Eli Lilly and Company.

Issued: June 2020

Manufactured by Eli Lilly and CompanyIndianapolis, IN 46285, USA

Copyright © 2007, 2020, Eli Lilly and Company. All rights reserved.

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen meets the current dose accuracy and functional requirements of ISO 11608-1.

ILPILIS7525KP-0002-IFU-20200609

PACKAGE CARTON – Insulin Lispro Protamine and Insulin Lispro Injectable Suspension KwikPen Mix75/25™ 5ct

NDC 0002-8233-05

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension KwikPen Mix75/25™

For Single Patient Use Only

Dispense in this sealed carton.

U-100

100 units per mL

Needles not included

This device is recommended for use with Becton, Dickinson and Company’s insulin pen needles

For subcutaneous use only.

prefilled insulin delivery device

Rx only

5 x 3 mL Prefilled Pens

Read Insulin Delivery Device Instructions for Use

PACKAGE CARTON – INSULIN LISPRO PROTAMINE AND ISULIN LISPRO INJECTABLE SUSPENSION  KwikPen Mix75/25 5ct
(click image for full-size original)
INSULIN LISPRO PROTAMINE AND INSULIN LISPRO INJECTABLE SUSPENSION MIX75/25 KWIKPEN insulin lispro injection, suspension
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0002-8233
Route of Administration SUBCUTANEOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Insulin lispro (Insulin lispro) Insulin lispro 100 [iU] in 1 mL
Inactive Ingredients
Ingredient Name Strength
Protamine sulfate 0.28 mg in 1 mL
Glycerin 16 mg in 1 mL
Sodium Phosphate, Dibasic, Unspecified Form 3.78 mg in 1 mL
Metacresol 1.76 mg in 1 mL
Zinc .025 mg in 1 mL
Phenol .715 mg in 1 mL
Water
Hydrochloric acid
Sodium hydroxide
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0002-8233-05 5 SYRINGE in 1 CARTON contains a SYRINGE (0002-8233-01)
1 NDC:0002-8233-01 3 mL in 1 SYRINGE This package is contained within the CARTON (0002-8233-05)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA021017 02/12/2020
Labeler — Eli Lilly and Company (006421325)

Revised: 09/2020 Eli Lilly and Company

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.